Insider trading · Q3 2026 · CIK 2017526

Freenome, Inc. (FRNM) insider trading.

In Q3 2026, insiders at Freenome, Inc. reported 15 non-derivative transactions on 20 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
15
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
9
Last filed
2026-09-04

Insiders

InsiderRelationshipTransactionsBuysSales
RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterDirector, TenPercentOwner700
Elliott Aaron MatthewDirector, Officer · Chief Executive Officer100
Waksal HarlanOther100
Song KennethOther100
Perceptive Capital Solutions HoldingsOther100
Perceptive Life Sciences Master Fund Ltd / Edelman Joseph / Perceptive Advisors LLCTenPercentOwner100
Stone Adam LeoOther100
Altman Michael SethOther100
McKenna Mark C.Other100

Transactions

15 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-02Elliott Aaron MatthewF (D)71,920$15.25345,976Form 4
2026-07-20Waksal HarlanC (A)30,000—30,000Form 4
2026-07-20Song KennethC (A)30,000—30,000Form 4
2026-07-20Perceptive Capital Solutions HoldingsC (A)2,066,250—2,352,500Form 4
2026-07-20Perceptive Life Sciences Master Fund Ltd / Edelman Joseph / Perceptive Advisors LLCA (A)5,500,000$1010,871,847Form 4
2026-07-20RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterA (A)6,561,711—7,311,711Form 4
2026-07-20RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterA (A)970,950—970,950Form 4
2026-07-20RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterA (A)553,703—553,703Form 4
2026-07-20RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterA (A)908,103—908,103Form 4
2026-07-20RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterA (A)367,427—367,427Form 4
2026-07-20RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterA (A)4,918,411$1012,230,122Form 4
2026-07-20RA Capital Nexus Fund, L.P. / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund II, L.P. / RA Capital Healthcare Fund LP / Kolchinsky PeterA (A)336,965$101,245,068Form 4
2026-07-20Stone Adam LeoC (A)2,066,250—2,352,500Form 4
2026-07-20Altman Michael SethC (A)2,066,250—2,352,500Form 4
2026-07-20McKenna Mark C.C (A)30,000—30,000Form 4

Transaction codes in this quarter

Get FRNM insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=2017526&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · FRNM company page · Freenome, Inc. on SEC.gov

Questions

Are insiders buying or selling Freenome, Inc. (FRNM)?

In Q3 2026, insiders at Freenome, Inc. reported 15 non-derivative transactions on 20 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Freenome, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/frnm.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.